Elekta ABEKTAF 77 Gross Margin % is 39.52% as of Apr. 2026, which is 1% above its 10-year median of 39.20. GuruFocus rates EKTAF with a GF Score™ of 77/100 and a GF Value™ of $6.07 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Elekta AB ranks worse than 71.93% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Elekta AB's Gross Profit for the
three
months ended in Apr. 2026 was $203 Mil. Elekta AB's Revenue for the
three
months ended in Apr. 2026 was $514 Mil. Therefore, Elekta AB's Gross Margin % for the quarter that ended in Apr. 2026 was 39.52%.
Warning Sign:
Elekta AB gross margin has been in long-term decline. The average rate of decline per year is -1.2%.
The historical rank and industry rank for Elekta AB's Gross Margin % or its related term are showing as below:
EKTAF'
s Gross Margin % Range Over the Past 10 Years
Min: 37.37 Med: 39.2 Max: 43.69
Current: 37.39
During the past 13 years, the highestGross Margin % of Elekta AB was 43.69%. The lowest was 37.37%. And the median was 39.20%.
EKTAF's Gross Margin % is ranked worse than 71.93% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs EKTAF: 37.39
Elekta AB had a gross margin of 39.52% for the quarter that ended in Apr. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Elekta AB was -1.20% per year.
Elekta AB (OTCPK:EKTAF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Elekta AB had a gross margin of 39.52% for the quarter that ended in Apr. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Elekta AB Gross Margin % Related Terms
Elekta AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Elekta AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Elekta AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Elekta AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Elekta AB (EKTAF) has a Gross Margin % of 39.52% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Elekta AB and its competitors. This is near median its historical median of 39.20. Over the past decade, Elekta AB's Gross Margin % has ranged from 37.37 to 43.69. According to the industry distribution chart, Elekta AB ranks #579 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 71.9%.
Is Elekta AB's Gross Margin % too high?
Elekta AB's current Gross Margin % of 39.52% is near median its 10-year median of 39.20. Over the past 10 years, this metric has ranged from a low of 37.37 to a high of 43.69. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Elekta AB's value of 39.52% is 23.9% below this industry median. Based on the distribution chart, Elekta AB ranks #579 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Elekta AB has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #579 out of 805 companies for Gross Margin %. This places Elekta AB in the lower half of its industry. The industry median Gross Margin % is 51.94. Elekta AB's value of 39.52% is 23.9% below this benchmark. Historically, Elekta AB's own Gross Margin % has ranged from 37.37 to 43.69 over the past decade. While the company's 10-year median is 39.20 vs. the industry median of 51.94, Elekta AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elekta AB's current Gross Margin % of 39.52% is 23.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current Gross Margin % is 39.52%, which is near median its own 10-year median of 39.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.07, compared to a current price of $5.04 — trading 17% below its estimated fair value. The current Gross Margin % is 39.52%, which is near median its 10-year median of 39.20 and 23.9% below the Medical Devices & Instruments industry median of 51.94. Elekta AB's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Elekta AB (EKTAF), the current Gross Margin % is 39.52% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (EKTAF) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of $5.04 is trading 17% below its estimated GF Value™ of $6.07.
GuruFocus considers Elekta AB to be Modestly Undervalued.
Key valuation signals for EKTAF:
Gross Margin %: 39.52% (near median its 10-year median of 39.20)
GF Value™: $6.07 vs. price of $5.04 (17% below fair value)
Industry Position: 23.9% below the Medical Devices & Instruments median (#579 of 805)
No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
77GF Score
Get the complete analysis for EKTAF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKTAF has been successfully added to your 
